baber/WOPTO huggingface dataset:
Patent NZ-544860-A (NZ)
Title: Building wall structure
Inventor: LAVELL PETER MAXWELL
IPC: E04F19/04
Filed: 2004-06-23
Abstract: A removable wall skirting system is disclosed. In a wall structure where an interior wall cladding (30) is carried by a frame and in which a gap (50) is provided between a bottom edge of the cladding and a bottom wall frame member (l0) of the frame, the removable wall skirting system covers this gap (50) but allows easier detection of termite activity within the wall structure. Various means of removably attaching the wall skirting are disclosed including magnetic coupling (44, 46), clips (47), and rail (70) and slot (72).
Patent NZ-544886-A (NZ)
Title: Microstructured high pressure nozzle with an in-built filter function
Inventor: EICHER JOACHIM
IPC: A61M15/00
Filed: 2004-06-23
Abstract: (57) Abstract: The invention relates to a microstructured nozzle comprising a plurality of channels which are produced by microstructuring a plate-like body. The channels of said nozzle are disposed between projections, which have a diameter between 5 and 20 microns, which are arranged in rows next to each other, maybe in a zigzag configuration and which project out of the base plate, and the microstructured base plate is covered with a cover plate. The channels are defined within narrow boundaries according to shape, cross-sectional area and length. The nozzle contains a filter as a primary structure and a secondary structure is arranged downstream from the filter. The nozzle is, for example, used with a sprayer or atomiser enabling an aerosol to be produced from a liquid which contains a medicament.
Patent NZ-547363-A (NZ)
Title: 6-(Aminocarbonyl-phenyl) triazolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same
Inventor: TORMO I BLASCO JORDI
IPC: A01N43/90
Filed: 2004-12-17
Abstract: Disclosed are triazolopyrimidines of formula (I), wherein the substituents have the following meaning: R1, R2 represent hydrogen, alkyl, alkyl halide, cycloalkyl, halocycloalkyl, alkenyl, haloalkenyl, cycloalkenyl, halocycloalkenyl, alkinyl, haloalkinyl, or phenyl, naphthyl, or a five-membered to six-membered saturated, partially unsaturated, or aromatic heterocycle containing one to four heteroatoms from the group comprising O, N, and S. R1 and R2 can also form a five-membered or six-membered heterocyclyl or heteroaryl along with the nitrogen atom to which the same are bonded, said heterocyclyl or heteroaryl being bonded via N, while optionally containing an additional heteroatom from the group comprising O, N, and S as a ring member and being optionally substituted according to the description; L represents halogen, cyano, alkyl, alkyl halide, alkoxy, alkenyloxy, or alkoxy carbonyl; m represents 1, 2, 3, or 4, the groups L being optionally different if m is greater than 1; X represents halogen, cyano, alkyl, alkyl halide, alkoxy, or haloalkoxy. Also disclosed are methods and intermediate products for producing said compounds, substances containing the same, and the use thereof for controlling plant-pathogenic fungi.
Patent NZ-560845-A (NZ)
Title: Antineoplastic combinations of CCI-779 and EKB-569
Inventor: RABINDRAN SRIDHAR KRISHNA
IPC: A61K31/00
Filed: 2002-08-06
Abstract: Disclosed is the use of CCl-779 in the preparation of a medicament for simultaneous, separate or sequential use with EKB-569 in the treatment of neoplasm in a mammal. Also disclosed is the use of EKB-569 in the preparation of a medicament for simultaneous, separate or sequential use with CCI-779 in the treatment of neoplasm in a mammal.
Patent NZ-562046-A (NZ)
Title: Electrical appliance for use with batteries
Inventor: DABDOUB DAVID ANTHONY
IPC: H02J7/00
Filed: 2006-03-29
Abstract: Disclosed is a battery charger (10) for charging batteries with different sizes. The apparatus includes battery charging circuitry; a first region (28); contacts (56a, 56b, 56c) in electrical communication with the circuitry adapted to make contact with batteries in the first region; a second region (30); and contacts (58a, 58b, 58c) in electrical communication with the circuitry adapted to make contact with batteries in the second region. The first region is adapted to selectively receive one of a first cylindrical battery with a radius or a first plurality of cylindrical batteries with smaller radii than the first battery, the first plurality being radially offset from the position of the first battery. The first region is further adapted to receive a rectangular 9 volt battery. The second region is adapted to receive one of a second cylindrical battery with a radius or a second plurality of cylindrical batteries with smaller radii than the first battery, the second plurality being radially offset from the position of the second battery.
Patent NZ-562685-A (NZ)
Title: 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
Inventor: TIMMERS CORNELIS MARIUS
IPC: A61K31/47
Filed: 2006-05-02
Abstract: Disclosed is a 4-phenyl-5-oxo-1, 4, 5, 6, 7, 8-hexahydroquinoline derivative according to Formula I wherein the substituents are defined as in the description, or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of fertility disorders.
Patent NZ-562818-A (NZ)
Title: Multilumen catheters and methods for their use
Inventor: CONSTANTZ BRENT R
IPC: A61F2/958
Filed: 2003-03-18
Abstract: A multilumen catheter is provided. The catheter (10) include a proximal end (14) and a distal end (12) separated by a non-coaxial multilumen tube, and includes a three port manifold (18) at its proximal ends, where each port of the three ports (11a, 11b, 11c) of the multiport manifold comprises a female luer valve (15). The catheter contains or is in fluid communication with an acidic dissolution fluid. Also provided are systems for use in flushing a vascular site with fluid, usually at least two different fluids, where the subject systems are made up of two multilumen catheters according to the subject invention, where one of the catheters is inserted inside of the other. In addition, kits comprising various components of the subject systems, e.g., at least two different multilumen catheters, are provided. The subject multilumen catheters, systems and kits find use in a variety of different applications in which it is desired to flush a vascular site with at least one and preferably two different fluids, where particular applications of interest include the treatment of vascular lesions.
Patent NZ-563337-A (NZ)
Title: Encoding an audio signal using heirarchical filtering and joint coding of tonal components and time-domain components
Inventor: SHMUNK DMITRY V
IPC: G10L19/00
Filed: 2006-06-16
Abstract: Disclosed is a method of encoding an input signal. The method includes the steps of: using a hierarchical filterbank (HFB) to decompose an input signal (100) into a multi-resolution time/frequency representation; extracting tonal components at multiple frequency resolutions from the time/frequency representation; extracting residual components from the time/frequency representation; ranking the components based on their relative contribution to decoded signal quality (103,107,109); quantizing and encoding the components (102,107,108); and eliminating a sufficient number of the lowest ranked encoded components (115) to form a scaled bit stream (116) having a data rate less than or approximately equal to a desired data rate.
Patent NZ-564065-A (NZ)
Title: Pyrrolopyridines useful as inhibitors of protein kinase
Inventor: LEDEBOER MARK W
IPC: A61K31/437
Filed: 2006-05-22
Abstract: The disclosure relates to compounds of formula (I), wherein Q, Z, R1, R2 , and R3 are as defined in the specification useful as inhibitors of protein kinases, particularly of JAK family and ROCK family kinases. The disclosure also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders, such as atherosclerosis, hypertension, erectile dysfunction (ED), reperfusion/ischemia, stroke, cerebral vasospasm, coronary vasospasm, cardiac hypertrophy, glaucoma, asthma, transplant rejection and the like.
Patent NZ-569888-A (NZ)
Title: Fluid dispensing apparatus with a valve assembly, an expandable bladder and a cavity
Inventor: DUNCAN WILLIAM JAMES
IPC: A62C13/66
Filed: 2007-01-29
Abstract: A fluid dispensing apparatus (10) is disclosed. The apparatus comprises a rigid outer container (1), a valve assembly, an expandable bladder and a cavity (3). A valve assembly is mounted to the outer container. The valve assembly is mounted to the outer container (1) for charging or discharging the apparatus (10). The valve assembly comprises a charging valve (9a) and a discharging valve (9). The expandable bladder is located within the outer container (1) for containing a dischargeable fluid (5) to be displaced from the apparatus (10). The cavity (3) is located between the outer container (1) and the bladder for containing pressurising fluid (5a). Prior to its first use, the apparatus (10) is in a condition in which the bladder is substantially empty of dischargeable fluid (5) and a cavity (3) is charged will pressurising fluid (5a) at a pressure that is sufficient to substantially dispense a dischargeable fluid (5) from the bladder during its use.
Patent NZ-571321-A (NZ)
Title: Secure electronic transaction system
Inventor: SANCHEZ JAVIER
IPC: G06Q20/00
Filed: 2007-02-22
Abstract: A method for electronically processing transactions is disclosed. A point-of-sale terminal receives information for a financial transaction card and information for a financial transaction and the point-of-sale terminal encrypts the financial card information and the financial transaction information into a first encrypted message. This first encrypted message is transmitted to a computer. This computer then encrypts the first encrypted message into a second encrypted message and transmits this second encrypted message to a network access controller. The network access controller decrypts the second encrypted message into a decrypted message; and transmits the decrypted message to a host processor for authorization.
Patent NZ-571858-A (NZ)
Title: Methods of treating, reducing and inhibiting the appearance of ageing in the skin
Inventor: GRANVILLE DAVID JAMES
IPC: A61K8/96
Filed: 2007-03-09
Abstract: 571858 Discloses the use of granzyme B inhibitor for maintaining a youthful appearance of the skin, reducing the appearance of ageing, inhibiting the appearance of ageing, cosmetic methods and a method of identifying a granzyme B inhibitor.
Patent NZ-577698-A (NZ)
Title: Ampoules comprising an elongated neck portion which prevents suspended particles within the liquid from reaching the head of the ampoule
Inventor: MCAFFER IAN GARDENER CAMERON
IPC: A61J1/06
Filed: 2007-11-22
Abstract: Disclosed is an ampoule, comprising: a body comprising a reservoir for up to 50ml of liquid; a removable head portion comprising a bulb; and a neck portion, linking the body to the head portion, comprising a channel through which liquid in the reservoir can exit the ampoule when the head portion has been removed, wherein the neck portion comprises a trap to prevent suspended particles in the liquid which have settled from reaching the head portion, and wherein the bulb is in fluid communication with the channel of the neck portion.
Patent NZ-577732-A (NZ)
Title: Wine rack assembly
Inventor: PERRETT CHRIS
IPC: A47B73/00
Filed: 2009-06-16
Abstract: A wine rack assembly 10 including a first wall 12 defined by a first plurality of parallel straps 14 and interconnecting transverse straps 16, a second wall 18 defined by a second plurality of parallel straps 14 and interconnecting transverse straps 16, and brace members 20 having crossed slots in ends for engagement with the straps of the first and second walls 12 18, the walls 12 18 being connected to and held in a spaced apart configuration by the brace members 20 located at the junction of each parallel strap 14 and transverse strap 16, adjacent brace members 20 providing support for a bottle 24, wherein at least one of the parallel straps 14 or transverse straps 16 having securing means for cooperation with the slots to thereby inhibit disconnection of the straps 14 16 from the brace members 20.
Patent NZ-578078-A (NZ)
Title: Heterocyclic-substituted piperidine as orl-1 ligands
Inventor: BABA YOSHIYASU
IPC: C07D401/04
Filed: 2008-01-15
Abstract: Disclosed are piperidine compounds that have a phenyl ring fused with a diaza heterocyclic ring of formula (I) where the substituents are as disclosed in the description. Examples of compounds of formula (I) are 1-(1-cyclooctylpiperidin-4-yl)-8-methyl-1H-benzo[b] [1,4 ]diazepine-2,4(3H,5H)-dione and 1-(1-cyclooctylpiperidin-4-yl)-7 -fluoroquinoxaline-2,3(1H,4H)-dione. Also disclosed is a composition comprising a compound of formula (I), an in vitro method of modulating ORL-1 receptor function in a cell, the use of a compound of formula (I) in the manufacture of a medicament for treating pain, a memory disorder, obesity, constipation, urinary incontinence, anxiety, cough, diarrhoea, high blood pressure, epilepsy, anorexia/cachexia, or drug abuse; a kit comprising an amount of a compound of formula (I) and a method of preparing a composition comprising the steps of combining a compound of formula (I) with a pharmaceutically acceptable carrier or excipient.
Patent NZ-586978-A (NZ)
Title: A process for the ultrapurification of alginates
Inventor: BASTA GIUSEPPE PIETRO PIO
IPC: C08L5/04
Filed: 2009-01-21
Abstract: Disclosed is a process for obtaining solutions of not structurally modified salts of alginate with an endotoxin content of less than 20EU/g. The process comprises addition of commercial grade alginate powder to a saline solution, until obtainment of an alginate solution having a concentration ranging from 1.6 to 2.0% by weight and pH adjustment in the range 7.4 - 7.6; filtration of the solution obtained on at least one hydrophilic filter and recovery of the obtained solution wherein the obtained solution is subjected to filtration on a hydrophobic filter and the obtained solution is recovered without dialysis.
Patent NZ-590047-A (NZ)
Title: Substituted n-oxide pyrazine derivatives
Inventor: LOCHEAD ALISTAIR
IPC: A61P25/28
Filed: 2009-06-25
Abstract: Disclosed are pyrazine N-oxide derivatives which act as GSK3b inhibitors and are represented by the general formula (I), wherein: R1 is pyridin-4-yl or a halogen atom; R2, R3 and R5 are all hydrogen and R4 represents a phenylalkyl group, which is optionally substituted by 1 to 4 substituents selected from a alkyl group, halo, haloalkyl, hydroxyl, alkoxy group, haloalkoxy, alkylsulfonyl, nitro, cyano, amino, monoalkylamino, dialkylamino, acetoxy, or an aminosulphonyl group; in the form of a free base or an addition salt, solvate or a hydrate thereof. Or particular importance are the compounds N-(2-phenylethyl)-6-pyridin-4-ylpyrazin-2-amine 4-oxide, (+/-)2-[(4-oxido-6-pyridin-4-ylpyrazin-2-yl)amino]-1-phenylethanol, (+/-)6-2-[(6-chloro-4-oxidopyrazin-2-yl)amino]-1-phenylethanol and 6-chloro-N-(2-phenylethyl)pyrazin-2-amine 4-oxide. Further disclosed is a pharmaceutical composition which comprises a compound as defined above for the treatment of neurodegenerative diseases (such as Alzheimer's disease, Parkinson's disease, tauopathies, vascular dementia; acute stroke, traumatic injuries etc.); non-insulin dependent diabetes; obesity; manic depressive illness; schizophrenia; alopecia; cancer; parenchymal renal diseases or muscle atrophy; malaria; bone diseases etc.
Patent NZ-606550-A (NZ)
Title: Pharmaceutical composition for the prolonged release of trimetazidine
Inventor: CHRISTOPHE HERMELIN
IPC: A61J3/10
Filed: 2013-02-01
Abstract: Composition for the prolonged release of trimetazidine wherein the inner phase comprises trimetazidine coated onto a neutral core and the outer layer comprises a retardant and an anti-agglomerant. Where the retardant may be one of ethylcellulose, cellulose acetate, cellulose acetate butyrate, cellulose acetate propionate, cellulose acetate phthalate, hydroxypropyl methylcellulose acetate succinate and/or polymethacrylates and the anti-agglomerant is one of talc, colloidal silicon dioxide, magnesium stearate, stearic acid and/or sodium fumaryl stearate. The trimetazidine may be coated onto an inert core. The composition may be used for prophylactic treatment of angina pectoris, in the course of chorioretinal disorders and also for the treatment of vertigo of vascular origin.
Patent NZ-625852-A (NZ)
Title: Treatment of seborrhoea
Inventor: MACRIDES THEODORE
IPC: A61P17/18
Filed: 2012-12-14
Abstract: The disclosure relates to the use of a composition in the treatment of seborrhoea in a patient, which comprises an effective amount of (24RS) scymnol, an ester thereof or a pharmaceutically acceptable salt of a said ester, together with a pharmaceutically acceptable carrier or diluent.
Patent NZ-627311-A (NZ)
Title: Improvements in, or relating to, mounting
Inventor: GRANT HOWARD BAGULEY
IPC: E04H17/22
Filed: 2013-07-10
Abstract: Disclosed is a glass sheet or panel fence mounting, adapted to hold at least part of a sheet fence to a structure, and able to be adjustable in height, angle or distance from a structure to allow the fence to be installed vertically despite of the orientation of the structure. The mounting comprises a body to receive and hold a portion of the sheet, a first location on the body to engage with a first height adjustable height fastening, and a second location on the body to engage with a second height adjustable fastening. The first and second height adjustable fastenings mounted from the structure are adjusted to provide a desired height and angle of the body to the structure and the body is locked to them. Preferably the mounting holds the sheet on a lower edge thereof. Preferably the first and second height adjustable fastenings are threaded fastenings. Preferably the first and second height adjustable fastenings each have a lower engaging member below a portion of each the body, whereby adjustment of the lower engaging member can adjust the desired height and angle.
Patent NZ-631084-A (NZ)
Title: Sheet molding and hemostatic material
Inventor: KAGEYAMA YUKAKO
IPC: A61P7/04
Filed: 2013-05-13
Abstract: Disclosed herein is a sheet product of a polymer composition that contains at least one type of protein substance selected from among the group consisting of fibrinogens and thrombins and at least one type of polymer selected from an aliphatic polyester and a water-soluble polymer, wherein the aliphatic polyester is selected from polylactic acid, polyglycolic acid, polycaprolactone, polyglycerol sebacate, polyhydroxyalkanoic acid, polybutylene succinate, a copolymer thereof, and a mixture thereof, the water-soluble polymer is selected from a polymer having an N-vinyl cyclic lactam unit, hydroxypropyl cellulose, methyl cellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose, carboxymethyl cellulose sodium, a mixture thereof, polyethyleneoxide, polyvinylalcohol, hyaluronic acid, dextran, pullulan, starch, and a mixture thereof, and at least part of the protein is incorporated into the polymer composition as protein particles. Also disclosed is a laminated sheet molding containing a first polymer composition layer containing a fibrinogen and a water-soluble polymer and a second polymer composition layer containing a thrombin and an aliphatic polyester. These sheet moldings are applied to wound sites and function as hemostatic materials.
Patent NZ-706892-A (NZ)
Title: Barrier system
Inventor: HAYDEN WALLACE
IPC: E01F15/04
Filed: 2013-08-20
Abstract: A barrier system including a guardrail, a support (3) to hold the guardrail in position and a fastener to attach the guardrail to the support is disclosed. The support has a weakened zone (16), around an aperture (13) for the fastener, to facilitate the fastener releasing from the support when the support is subject to impact forces. The zone may immediately release the fastener or initially deform a section (20) of the support delimited by the zone, then release that section. A number of zone shapes and configurations are disclosed.
Patent NZ-717887-A (NZ)
Title: Treatment of cancer with tor kinase inhibitors
Inventor: RAYMON HEATHER
IPC: G01N33/50
Filed: 2013-10-17
Abstract: Provided are methods for treating prostate cancer using TOR kinase (mTOR) inhibitors. Further provided are methods of determining the response of prostate cancers to TOR kinase inhibitors by measuring the phosphorylation of S6RP, 4E-BP1, AKT or DNA-PK. In an embodiment the TOR kinase inhibitor is a compound of formula (IV), where the variables are as defined in the specification, such as 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one .
Patent NZ-720664-A (NZ)
Title: Metallurgical furnace
Inventor: CHAO JOHN
IPC: F27B1/10
Filed: 2013-12-20
Abstract: In order to prevent formation of gaps between bricks and cracks within the bricks, the present invention provides a metallurgical furnace including a refractory, which may include an inner layer, including bricks of a first type having a heat dissipation thickness, and bricks of a second type having a greater sacrificial thickness and protruding towards the furnace space. The furnace may include a force exerting member for contracting a segmented outer shell around the refractory, inward, as the refractory contracts when cooling. The force exerting member may include a tension member. The furnace may include a vertical compression member for exerting a compressive force upon the refractory, vertically compressing the refractory as it contracts. Moreover, in order to provide an adequate thermal insulation for the surrounding environment and barrier to prevent the escape of toxic gases, the present invention provides a furnace that may include a cooling system, including a sleeve surrounding a layer of heated air, and air displacement members for displacing away the heated air. The furnace may include a roof, having suspension members extending therethrough, supporting an inner mesh, the inner mesh supporting insulating material. The furnace may also include an electrode seal having a plurality of shoes biased against the electrode(s).
Patent NZ-724656-A (NZ)
Title: High band excitation signal generation
Inventor: RAJENDRAN VIVEK
IPC: G10L19/24
Filed: 2015-03-31
Abstract: A particular method includes determining, at a device, a voicing classification of an input signal. The input signal corresponds to an audio signal. The method also includes controlling an amount of an envelope of a representation of the input signal based on the voicing classification. The method further includes modulating a white noise signal based on the controlled amount of the envelope. The method also includes generating a high band excitation signal based on the modulated white noise signal.
Patent NZ-735999-A (NZ)
Title: Autonomous connection switching in a wireless communication network
Inventor: ZHANG ZHAN
IPC: H04W36/08
Filed: 2014-01-30
Abstract: An access point (100-1) of a wireless communication network serves a connection to a user equipment (50). The access point (100-1) determines a plurality of target access points (100- 2, 100-3). Further, the access point (100-1) sends a message (204) to the user equipment (50). The message (204) indicates the plurality of target access points (100-2, 100-3) and authorizes the user equipment (50) to autonomously switch the connection to one or more of the target access points (100-2, 100-3).